October 06, 2026

NNS beverages may match water in weight control

Adults assigned to nonnutritive sweetened beverages or water maintained weight reductions through 104 weeks, with no statistically significant difference between groups.

MDSpire News

October 06, 2026

ACP puts hormone therapy first for menopause symptoms

Estrogen-based therapy is now recommended first for vasomotor symptoms, with SNRIs, SSRIs, gabapentin, and neurokinin receptor antagonists reserved for later lines.

MDSpire News

October 06, 2026

Breye Raises €67.5M for Oral DR Therapy

Series A financing for Phase II trial of danegaptide in non-proliferative diabetic retinopathy

The Ophthalmologist

October 05, 2026

Loneliness linked to fewer mental disease-free years

A healthy lifestyle was associated with a smaller loss of disease-free life expectancy related to social isolation, but the same pattern did not hold for loneliness. 

MDSpire News

October 05, 2026

Prenatal metformin not linked to developmental risk

Adjusted findings showed no association with developmental vulnerability overall or across any of the 5 developmental domains.

MDSpire News

October 01, 2026

Medical Oddities: Long workweeks meet erectile function

From work stress to lullabies, bay leaves, and one-legged cycling, medicine gets weird.

MDSpire News

September 29, 2026

Dietary fat type may matter after prostate cancer

The association was driven by cardiovascular disease and other cancers, not prostate cancer mortality.

MDSpire News

September 29, 2026

Wildfire pollution may pose cardiopulmonary risk

Wildfire-specific fine particulate matter was linked to larger hospitalization risk increases than pollution from nonwildfire sources.

MDSpire News

September 28, 2026

Metabolic Control May Shape Anti-VEGF Response in DME

Large real-world cohort suggests poor glycemic control may reduce the anatomical response to anti-VEGF therapy in diabetic macular edema

The Ophthalmologist

September 25, 2026

FDA monthly preview: Key October decisions to watch

Several FDA decisions across multiple specialties are expected this month.

MDSpire News